MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

MDT

88.96

+0.59%↑

VEEV

226.47

-0.52%↓

A

115.98

+2.05%↑

HQY

88.73

+1.89%↑

PDCO

31.27

+0.06%↑

Search

Stryker Corp

Închisă

SectorSănătate

377.64 1.24

Rezumat

Modificarea prețului

24h

Curent

Minim

366.48

Maxim

378.27

Indicatori cheie

By Trading Economics

Venit

-288M

546M

Vânzări

946M

6.4B

P/E

Medie Sector

48.094

63.778

EPS

4.01

Randament dividend

0.9

Marjă de profit

8.484

Angajați

53,000

EBITDA

385M

1.8B

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+16.61% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.90%

2.39%

Următoarele câștiguri

29 apr. 2025

Data viitoare de dividende

30 apr. 2025

Statistici piață

By TradingEconomics

Capitalizare de piață

-8.2B

142B

Deschiderea anterioară

376.4

Închiderea anterioară

377.64

Sentimentul știrilor

By Acuity

28%

72%

83 / 386 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Bullish Evidence

Stryker Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

28 ian. 2025, 21:55 UTC

Câștiguri

Stryker Sees Further Organic Sales Growth in 2025

28 ian. 2025, 21:46 UTC

Achiziții, Fuziuni, Preluări

Stryker to Sell Spinal Implants Business to Viscogliosi Brothers

6 ian. 2025, 22:18 UTC

Achiziții, Fuziuni, Preluări

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion -- Update

6 ian. 2025, 21:39 UTC

Achiziții, Fuziuni, Preluări

Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion

19 feb. 2025, 13:53 UTC

Achiziții, Fuziuni, Preluări

Stryker Files 8K - Asset Acquisition Or Disposition >SYK

19 feb. 2025, 13:30 UTC

Achiziții, Fuziuni, Preluări

Stryker Completes Acquisition Of Inari Medical, Inc., Providing Entry Into The High-growth Peripheral Vascular Segment >SYK

28 ian. 2025, 21:09 UTC

Achiziții, Fuziuni, Preluări

Stryker: Transaction Is Expected to Close in the U.S. in 1H 2025 >SYK

28 ian. 2025, 21:09 UTC

Achiziții, Fuziuni, Preluări

Stryker: Agreement Includes Binding Offer to Acquire Stryker's Spinal Implants Business in France >SYK

28 ian. 2025, 21:08 UTC

Achiziții, Fuziuni, Preluări

Stryker: After Closing, VB Spine Will Become a Strategic Partner to Stryker With Exclusive Access to Mako Spine and Copilot for Use With VB Spine's Implants in Spine Procedures >SYK

28 ian. 2025, 21:08 UTC

Achiziții, Fuziuni, Preluări

Stryker: Agreement to Sell U.S. Spinal Implants Business to Viscogliosi Brothers, LLC to Create Newly Formed Co Called VB Spine, LLC >SYK

28 ian. 2025, 21:06 UTC

Câștiguri

Stryker Sees Organic Net Sales Growth of 8% to 9% for 2025 >SYK

28 ian. 2025, 21:06 UTC

Câștiguri

Stryker Sees FY Adj EPS $13.45-Adj EPS $13.70 >SYK

28 ian. 2025, 21:05 UTC

Achiziții, Fuziuni, Preluări

Stryker: Announces Definitive Agreement for the Sale of U.S. Spinal Implants Business and Plans to Sell Related Intl Business

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Net $500M >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Adj EPS $4.01 >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Net $546M >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Net $500M >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Sales $6.4B >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q EPS $1.41 >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Adj EPS $4.01 >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q EPS $1.41 >SYK

28 ian. 2025, 21:05 UTC

Câștiguri

Stryker 4Q Sales $6.4B >SYK

17 ian. 2025, 21:20 UTC

Achiziții, Fuziuni, Preluări

Stryker Commences Tender Offer for All Outstanding Shrs of Common Stock of Inari Medical

13 ian. 2025, 19:30 UTC

Câștiguri

Update: Stryker Had A Good Year Last Year; Here's How It's Looking For 2025 -- IBD

7 ian. 2025, 09:58 UTC

Acțiuni populare

Stocks to Watch Tuesday: Nvidia, Uber, Tencent -- WSJ

6 ian. 2025, 22:03 UTC

Top știri
Achiziții, Fuziuni, Preluări

Stryker to Acquire Inari Medical in Deal Valued at $4.9B -- Update

6 ian. 2025, 21:49 UTC

Achiziții, Fuziuni, Preluări

Inari Medical Catapults -- Again -- After Stryker Confirms $4.9 Billion Deal -- IBD

6 ian. 2025, 21:24 UTC

Top știri
Achiziții, Fuziuni, Preluări

Stryker to Acquire Inari Medical in Deal Valued at $4.9B

6 ian. 2025, 21:11 UTC

Achiziții, Fuziuni, Preluări

Stryker: Inari's Innovative Pdt Portfolio Is Highly Complementary to Our Neurovascular Business >SYK

6 ian. 2025, 21:10 UTC

Achiziții, Fuziuni, Preluări

Stryker: Transaction Is Anticipated to Close by the End of the 1Q >SYK

Comparație

Modificare preț

Stryker Corp Așteptări

Obiectiv de preț

By TipRanks

16.61% sus

Prognoză pe 12 luni

Medie 435.3 USD  16.61%

Maxim 465 USD

Minim 400 USD

În baza a 22 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruStryker Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

22 ratings

18

Cumpărare

4

Păstrare

0

Vânzare

Scor tehnic

By Trading Central

372.77 / 374.61Suport & Rezistență

Termen scurt

Bullish Evidence

Termen mediu

Bearish Evidence

Termen lung

Neutral Evidence

Sentiment

By Acuity

83 / 386 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.